Merck’s colorectal cancer therapy fails late-stage trial
Merck faces setback as Keytruda combination trials fail to expand cancer treatment ahead of patent loss
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
lung cancer
AstraZeneca says lung cancer drug trial shows no significant improvement in overall survival
TROPION-Lung01 trial results fall short on overall survival, raising concerns for Dato-DXd's future
US FDA approves AstraZeneca’s non-small cell lung cancer treatment
Imfinzi gains expanded use, and AstraZeneca’s shares rise after a priority review for small cell lung cancer
Merck discontinues Phase 3 trial for lung cancer combo drug
When compared to patients in the control arm, patients in the vibostolimab and pembrolizumab fixed-dose combination arm…
TAGRISSO reduces disease progression or death by 84 % in Stage III EGFR-mutated lung cancer vs.…
First and only EGFR inhibitor and targeted treatment to show benefit in stage III setting, extending progression-free survival…
AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 bn sales by 2029:…
GlobalData reveals that a total of 39 small molecules have been commercialised for the treatment of lung cancer, with a total of…
Roche presents five-year survival outcomes for Tecentriq plus chemotherapy in ES-SCLC
IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with…
Enzene Biosciences launches Bevacizumab
Manufactured using Enzene Biosciences’ patented Continuous Manufacturing Process, Bevacizumab is a biosimilar to Avastin and will…
AstraZeneca and DHS Jammu partners to bring down lung cancer burden
Partnership to integrate Qure.ai’s smart artificial intelligent technology to detect lung cancer early on
Zydus Cadila gets tentative US FDA nod for Osimertinib Tablets
Osimertinib is a kinase inhibitor used to treat lung cancer